The Outliyr Index

How to read this board: every item carries three signals side by side. Community Signal shows what the people who tried it report. Evidence pairs an independent research grade with my BioHarmony take, clearly labeled as one voice among three. Momentum shows which way attention moved this week. No placement here is sponsored or for sale. Full methodology.

Scout leaderboard: who called it first

This week’s movers

No movers yet this week. Movement needs two weekly snapshots to compare, so a fresh board shows its first movers in week two. Weigh in below and help the next shift register.

Movers track attention, never evidence. How momentum works.

Proven 46

The research and the results agree. Start here.

Astaxanthin
Score
7.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
5.4%
Trend
Begins with Edition 2
Call it Weigh in
Blood-Flow Restriction Training
Score
8.2/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
0.6%
Trend
Begins with Edition 2
Call it Weigh in
BPC-157 In the news
Score
7.5/10
Evidence
B (good evidence)
Community
Be the first
Momentum
8.0%
Trend
Begins with Edition 2
Call it Weigh in
Bromantane (Ladasten)
Score
7.1/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Coenzyme Q10 (CoQ10 / Ubiquinol)
Score
7.1/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
Collagen Peptides
Score
7.6/10
Evidence
B (good evidence)
Community
Be the first
Momentum
3.1%
Trend
Begins with Edition 2
Call it Weigh in
Creatine Monohydrate
Score
8.7/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
5.1%
Trend
Begins with Edition 2
Call it Weigh in
Electrolytes
Score
8.8/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
43.4%
Trend
Begins with Edition 2
Call it Weigh in
Essential Amino Acids
Score
8/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
5.4%
Trend
Begins with Edition 2
Call it Weigh in
Full-Body EMS
Score
7.3/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
GHK-Cu In the news
Score
7.4/10
Evidence
B (good evidence)
Community
Be the first
Momentum
8.3%
Trend
Begins with Edition 2
Call it Weigh in
Glycine In the news
Score
7.9/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
7.0%
Trend
Begins with Edition 2
Call it Weigh in
Grass-Fed Whey Protein
Score
8.3/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
HRV Biofeedback
Score
9/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.3%
Trend
Begins with Edition 2
Call it Weigh in
Infrared Sauna
Score
7.4/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
22.2%
Trend
Begins with Edition 2
Call it Weigh in
KPV (Lys-Pro-Val) In the news
Score
7.1/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
L-Theanine
Score
7.9/10
Evidence
B (good evidence)
Community
Be the first
Momentum
5.2%
Trend
Begins with Edition 2
Call it Weigh in
Lactoferrin
Score
7.3/10
Evidence
B (good evidence)
Community
Be the first
Momentum
5.5%
Trend
Begins with Edition 2
Call it Weigh in
Lion's Mane
Score
7.2/10
Evidence
B (good evidence)
Community
Be the first
Momentum
21.1%
Trend
Begins with Edition 2
Call it Weigh in
Magnesium In the news
Score
8.7/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
43.8%
Trend
Begins with Edition 2
Call it Weigh in
Melatonin In the news
Score
8.2/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
21.6%
Trend
Begins with Edition 2
Call it Weigh in
Molecular Hydrogen
Score
8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
55.6%
Trend
Begins with Edition 2
Call it Weigh in
NAC (N-Acetylcysteine)
Score
8/10
Evidence
B (good evidence)
Community
Be the first
Momentum
1.2%
Trend
Begins with Edition 2
Call it Weigh in
Neurofeedback
Score
8.3/10
Evidence
B (good evidence)
Community
Be the first
Momentum
9.0%
Trend
Begins with Edition 2
Call it Weigh in
Norwegian 4x4
Score
8.5/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
PEMF (Pulsed Electromagnetic Field Therapy)
Score
7.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.3%
Trend
Begins with Edition 2
Call it Weigh in
Phosphatidylserine
Score
7.3/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
5.9%
Trend
Begins with Edition 2
Call it Weigh in
Polyphenols (Dietary)
Score
7.6/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
14.5%
Trend
Begins with Edition 2
Call it Weigh in
Red Light Therapy In the news
Score
8/10
Evidence
B (good evidence)
Community
Be the first
Momentum
23.5%
Trend
Begins with Edition 2
Call it Weigh in
Rucking (Weighted Walking)
Score
7.3/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Saffron
Score
8/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
8.8%
Trend
Begins with Edition 2
Call it Weigh in
Semax
Score
7.1/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
9.5%
Trend
Begins with Edition 2
Call it Weigh in
Shilajit
Score
7.4/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
5.4%
Trend
Begins with Edition 2
Call it Weigh in
Spermidine
Score
7.6/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
4.7%
Trend
Begins with Edition 2
Call it Weigh in
Spirulina
Score
7/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
7.7%
Trend
Begins with Edition 2
Call it Weigh in
Taurine
Score
8.1/10
Evidence
B (good evidence)
Community
Be the first
Momentum
12.4%
Trend
Begins with Edition 2
Call it Weigh in
TB-500 (Thymosin Beta-4 Fragment) In the news
Score
7.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Thymosin Alpha-1 In the news
Score
7.3/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
Thymosin Beta-4 (Tβ4)
Score
7.2/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Tongkat Ali
Score
7/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
5.2%
Trend
Begins with Edition 2
Call it Weigh in
Traditional Sauna (Finnish Dry-Heat)
Score
7.7/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Vagus Nerve Stimulation
Score
7.7/10
Evidence
B (good evidence)
Community
Be the first
Momentum
7.3%
Trend
Begins with Edition 2
Call it Weigh in
Vitamin C (Ascorbic Acid)
Score
7.7/10
Evidence
B (good evidence)
Community
Be the first
Momentum
3.4%
Trend
Begins with Edition 2
Call it Weigh in
Vitamin D3 + K2
Score
7.8/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
Whole-Body Vibration
Score
7.3/10
Evidence
B (good evidence)
Community
Be the first
Momentum
17.6%
Trend
Begins with Edition 2
Call it Weigh in
Zone 2 Cardio
Score
8.3/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
11.6%
Trend
Begins with Edition 2
Call it Weigh in

Promising 69

Real signal with real gaps. Worth a spot in your stack when the fit is right.

Adaptogenic Mushrooms (Reishi, Cordyceps, Chaga)
Score
5.8/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
AHK-Cu (Copper Tripeptide)
Score
6.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Aniracetam
Score
6.4/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
3.3%
Trend
Begins with Edition 2
Call it Weigh in
Apigenin
Score
6.7/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
9.1%
Trend
Begins with Edition 2
Call it Weigh in
ARA-290 (Cibinetide)
Score
6.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Ashwagandha
Score
6.8/10
Evidence
B (good evidence)
Community
Be the first
Momentum
14.9%
Trend
Begins with Edition 2
Call it Weigh in
Berberine In the news
Score
6.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
15.8%
Trend
Begins with Edition 2
Call it Weigh in
Ca-AKG (Calcium Alpha-Ketoglutarate)
Score
6.5/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Cagrilintide (AM833) In the news
Score
5.8/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Celebrex (Celecoxib)
Score
5.8/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
1.0%
Trend
Begins with Edition 2
Call it Weigh in
Cerebrolysin
Score
6.3/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
2.5%
Trend
Begins with Edition 2
Call it Weigh in
Chlorella
Score
6.5/10
Evidence
D (early evidence)
Community
Be the first
Momentum
8.1%
Trend
Begins with Edition 2
Call it Weigh in
CJC-1295 No DAC (Mod GRF 1-29)
Score
5.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Cold Plunge
Score
6.3/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
11.1%
Trend
Begins with Edition 2
Call it Weigh in
Colostrum
Score
6.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
24.9%
Trend
Begins with Edition 2
Call it Weigh in
DSIP (Delta Sleep-Inducing Peptide) In the news
Score
6.1/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Dynamine (Methylliberine)
Score
5.8/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
Earthing
Score
6.8/10
Evidence
D (early evidence)
Community
Be the first
Momentum
2.8%
Trend
Begins with Edition 2
Call it Weigh in
Epitalon In the news
Score
6.7/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
5.9%
Trend
Begins with Edition 2
Call it Weigh in
Ergothioneine
Score
6.6/10
Evidence
D (early evidence)
Community
Be the first
Momentum
6.7%
Trend
Begins with Edition 2
Call it Weigh in
Exogenous Ketones
Score
5.9/10
Evidence
D (early evidence)
Community
Be the first
Momentum
9.4%
Trend
Begins with Edition 2
Call it Weigh in
Fisetin
Score
6.8/10
Evidence
Not graded
Community
Be the first
Momentum
4.3%
Trend
Begins with Edition 2
Call it Weigh in
Fucoidan (Brown Seaweed Polysaccharide)
Score
6.4/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
Full-Spectrum Hemp (CBD)
Score
6.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.2%
Trend
Begins with Edition 2
Call it Weigh in
Glutathione (GSH)
Score
6.2/10
Evidence
D (early evidence)
Community
Be the first
Momentum
7.2%
Trend
Begins with Edition 2
Call it Weigh in
GlyNAC (Glycine + N-Acetylcysteine)
Score
6.7/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Gonadorelin (GnRH)
Score
6.3/10
Evidence
B (good evidence)
Community
Be the first
Momentum
2.2%
Trend
Begins with Edition 2
Call it Weigh in
High-Dose Melatonin
Score
6.7/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Hyaluronic Acid
Score
6.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
6.2%
Trend
Begins with Edition 2
Call it Weigh in
Hyperbaric Oxygen Therapy
Score
6.2/10
Evidence
B (good evidence)
Community
Be the first
Momentum
10.6%
Trend
Begins with Edition 2
Call it Weigh in
Ipamorelin In the news
Score
6.2/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
6.5%
Trend
Begins with Edition 2
Call it Weigh in
Kava (Piper methysticum)
Score
6/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.3%
Trend
Begins with Edition 2
Call it Weigh in
Ketogenic Diet
Score
6.6/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
33.2%
Trend
Begins with Edition 2
Call it Weigh in
Kisspeptin-10
Score
6.4/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
Melanotan I (Afamelanotide)
Score
6.2/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Metformin In the news
Score
6.9/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
10.9%
Trend
Begins with Edition 2
Call it Weigh in
Methylene Blue
Score
6.1/10
Evidence
B (good evidence)
Community
Be the first
Momentum
13.1%
Trend
Begins with Edition 2
Call it Weigh in
Modafinil
Score
5.9/10
Evidence
B (good evidence)
Community
Be the first
Momentum
5.3%
Trend
Begins with Edition 2
Call it Weigh in
MOTS-c In the news
Score
6.5/10
Evidence
D (early evidence)
Community
Be the first
Momentum
18.6%
Trend
Begins with Edition 2
Call it Weigh in
NMN (Nicotinamide Mononucleotide)
Score
6.3/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.2%
Trend
Begins with Edition 2
Call it Weigh in
NR (Nicotinamide Riboside)
Score
6.1/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.3%
Trend
Begins with Edition 2
Call it Weigh in
Omega-3
Score
6.8/10
Evidence
B (good evidence)
Community
Be the first
Momentum
15.1%
Trend
Begins with Edition 2
Call it Weigh in
Orforglipron (Foundayo)
Score
5.8/10
Evidence
B (good evidence)
Community
Be the first
Momentum
18.5%
Trend
Begins with Edition 2
Call it Weigh in
Oxiracetam
Score
6.4/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
2.8%
Trend
Begins with Edition 2
Call it Weigh in
Oxytocin (Intranasal)
Score
6.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.3%
Trend
Begins with Edition 2
Call it Weigh in
Paraxanthine (Enfinity)
Score
6.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Pinealon (Glu-Asp-Arg) In the news
Score
6.4/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Piracetam (Nootropil) In the news
Score
6.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
Quercetin
Score
6.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
8.2%
Trend
Begins with Edition 2
Call it Weigh in
Quinton Marine Plasma (Seawater Minerals)
Score
5.9/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Rapamycin
Score
6.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
7.1%
Trend
Begins with Edition 2
Call it Weigh in
Sabroxy (Oroxylum indicum Extract)
Score
6.6/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Selank
Score
6.9/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
4.4%
Trend
Begins with Edition 2
Call it Weigh in
Semaglutide In the news
Score
6/10
Evidence
B (good evidence)
Community
Be the first
Momentum
32.6%
Trend
Begins with Edition 2
Call it Weigh in
Senolytics
Score
6.6/10
Evidence
D (early evidence)
Community
Be the first
Momentum
7.0%
Trend
Begins with Edition 2
Call it Weigh in
Sermorelin (GHRH 1-29)
Score
5.9/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
SNAP-8 (Acetyl Octapeptide-3)
Score
6.2/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Sprinting (Sprint Interval Training)
Score
6.9/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.2%
Trend
Begins with Edition 2
Call it Weigh in
SS-31 (Elamipretide) In the news
Score
6/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Sulforaphane In the news
Score
6.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
5.3%
Trend
Begins with Edition 2
Call it Weigh in
Tesamorelin In the news
Score
6.2/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
8.0%
Trend
Begins with Edition 2
Call it Weigh in
Thymalin
Score
5.9/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Thymulin (Zinc-Thymulin)
Score
6.6/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Time-Restricted Eating
Score
6.9/10
Evidence
B (good evidence)
Community
Be the first
Momentum
7.2%
Trend
Begins with Edition 2
Call it Weigh in
Tirzepatide In the news
Score
6.1/10
Evidence
B (good evidence)
Community
Be the first
Momentum
12.0%
Trend
Begins with Edition 2
Call it Weigh in
TUDCA (Tauroursodeoxycholic Acid)
Score
6.7/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.2%
Trend
Begins with Edition 2
Call it Weigh in
Urolithin A
Score
6.5/10
Evidence
D (early evidence)
Community
Be the first
Momentum
11.7%
Trend
Begins with Edition 2
Call it Weigh in
Vilon (Lys-Glu)
Score
6.4/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
VK2735 (Viking Therapeutics)
Score
5.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in

Experimental 32

Early data and early adopters. Test carefully and track your own response.

5-Amino-1MQ In the news
Score
4.9/10
Evidence
E (thin evidence)
Community
Be the first
Momentum
33.3%
Trend
Begins with Edition 2
Call it Weigh in
AOD-9604
Score
4.6/10
Evidence
E (thin evidence)
Community
Be the first
Momentum
33.3%
Trend
Begins with Edition 2
Call it Weigh in
C15 (Pentadecanoic Acid)
Score
4.9/10
Evidence
E (thin evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
C60 (Buckminsterfullerene)
Score
4.9/10
Evidence
E (thin evidence)
Community
Be the first
Momentum
0.2%
Trend
Begins with Edition 2
Call it Weigh in
CagriSema (Cagrilintide + Semaglutide)
Score
5.1/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
CJC-1295 In the news
Score
5.5/10
Evidence
D (early evidence)
Community
Be the first
Momentum
6.7%
Trend
Begins with Edition 2
Call it Weigh in
CJC-1295 DAC
Score
4.8/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Dihexa
Score
4.4/10
Evidence
D (early evidence)
Community
Be the first
Momentum
5.2%
Trend
Begins with Edition 2
Call it Weigh in
Ephedrine
Score
5.3/10
Evidence
B (good evidence)
Community
Be the first
Momentum
3.4%
Trend
Begins with Edition 2
Call it Weigh in
FOXO4-DRI
Score
4.1/10
Evidence
E (thin evidence)
Community
Be the first
Momentum
4.9%
Trend
Begins with Edition 2
Call it Weigh in
GHRP-2 (Pralmorelin)
Score
5.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
GHRP-6
Score
5.1/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
3.6%
Trend
Begins with Edition 2
Call it Weigh in
Humanin
Score
5.5/10
Evidence
D (early evidence)
Community
Be the first
Momentum
4.6%
Trend
Begins with Edition 2
Call it Weigh in
LL-37 (Cathelicidin)
Score
4.7/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
Mazdutide (IBI362)
Score
5.6/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Melanotan II
Score
4.6/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
7.1%
Trend
Begins with Edition 2
Call it Weigh in
MK-677 (Ibutamoren) In the news
Score
4.9/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
NAD+ (Direct) In the news
Score
5/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.4%
Trend
Begins with Edition 2
Call it Weigh in
Ozone Therapy
Score
5.1/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
6.2%
Trend
Begins with Edition 2
Call it Weigh in
P21 (P021)
Score
5/10
Evidence
E (thin evidence)
Community
Be the first
Momentum
11.1%
Trend
Begins with Edition 2
Call it Weigh in
PE-22-28
Score
4.9/10
Evidence
E (thin evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Pentosan Polysulfate (Elmiron)
Score
4.7/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Phenylpiracetam (Phenotropil)
Score
5.5/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Pine Pollen In the news
Score
5.7/10
Evidence
D (early evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
PT-141 (Bremelanotide)
Score
5.4/10
Evidence
B (good evidence)
Community
Be the first
Momentum
0.1%
Trend
Begins with Edition 2
Call it Weigh in
Resveratrol
Score
5.6/10
Evidence
E (thin evidence)
Community
Be the first
Momentum
6.2%
Trend
Begins with Edition 2
Call it Weigh in
Retatrutide In the news
Score
5.6/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
34.6%
Trend
Begins with Edition 2
Call it Weigh in
SLU-PP-332 In the news
Score
4.7/10
Evidence
D (early evidence)
Community
Be the first
Momentum
5.8%
Trend
Begins with Edition 2
Call it Weigh in
Survodutide (BI 456906)
Score
5.1/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.0%
Trend
Begins with Edition 2
Call it Weigh in
Tesofensine
Score
5/10
Evidence
B (good evidence)
Community
Be the first
Momentum
6.2%
Trend
Begins with Edition 2
Call it Weigh in
TRT (Testosterone Replacement Therapy) In the news
Score
5.7/10
Evidence
A (strong evidence)
Community
Be the first
Momentum
0.2%
Trend
Begins with Edition 2
Call it Weigh in
VIP (Vasoactive Intestinal Peptide) In the news
Score
5.4/10
Evidence
C (mixed evidence)
Community
Be the first
Momentum
0.3%
Trend
Begins with Edition 2
Call it Weigh in

Overhyped/Fading 0

The claims outrun the evidence, or the moment already passed.

Nothing is flagged as overhyped or fading yet. Items land here when weekly momentum outruns the evidence or goes into confirmed decline, and that verdict takes at least two weeks of momentum history.

Missing something?

Nominate any intervention you think belongs on this board. Clean nominations go live at Experimental once enough verified members signal interest, and the first scout keeps permanent credit on the item page.